The Patent Finder

Hansa Biopharma AB

16 patents currently held · Updated Nov 16, 2026
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.

Previously recorded as Hansa Medical AB (to 2020)

4
Ending by 2030
Jun 2028
Next term end

When these terms end

Held patents by the year their term ends
20262027202820292030203120322033203420352036203720382039204020412042204320442045

Fee deadlines

Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
  • 1 fee due Dec 6, 2026
    The maintenance fee for Cysteine Protease (US 11,667,905) comes due Dec 6, 2026. Unpaid by Jun 7, 2027, it lapses early.

Which patents, and when each one lapses · Pro

Recent changes

Nothing was recorded against this company's patents in the last 90 days.

Patents held now

Soonest term end first. Each date below is computed on that patent's own page, which shows the rule, the adjustments and the fee history it was derived from.
PatentTitleStatus Expires Confidence
US 9,784,741Diagnostic method
In force
 · From the USPTO record
In forceFrom the USPTO record
US 8,133,483Method of treating or preventing a disease or condition mediated by pathogenic IgG antibodies
In force
 · From the USPTO record
In forceFrom the USPTO record
US 8,518,648Diagnostic method
In force
 · From the USPTO record
In forceFrom the USPTO record
US 8,889,128Use of the endoglycosidase endos for treating immunoglobulin G mediated diseases
In force
 · From the USPTO record
In forceFrom the USPTO record
US 10,126,312Diagnostic method for urinary tract infection
In force
 · From the USPTO record
In forceFrom the USPTO record
US 9,707,279Treatment for IgE-mediated disease
In force
 · From the USPTO record
In forceFrom the USPTO record
US 9,759,720Diagnostic method for bacterial meningitis
In force
 · From the USPTO record
In forceFrom the USPTO record
US 10,973,889Method for improving the benefit of organ transplant
In force
 · From the USPTO record
In forceFrom the USPTO record
US 10,696,959Cysteine Protease
In force
 · High confidence
In forceHigh confidence
US 10,758,597Variant Cysteine Proteases
In force
 · High confidence
In forceHigh confidence
10 of 16 patents shown.
Pro members see all 16.
Pro members: see all 16 patents
Also on record, not counted in the 16: 3 lapsed for an unpaid fee. List them

Sources and methods

Compiled from the USPTO record, grants, published applications and recorded assignments, not yet reviewed by hand. How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.

Published applications

US patent applications published under this name that have not become patents. An application is published about eighteen months after its earliest filing; one that has not been published is in no public record.

5 pending · 1 no status recorded

List them

The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 16, 2026 · includes USPTO assignment & status data published Nov 16, 2026 and grant & fee data published Nov 10, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited